Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Rio Tinto zips higher as Reckitt Benckiser falls

Fri, 10th Feb 2017 17:10

(ShareCast News) - FTSE 100 is higher on Friday afternoon thanks to a string of mining behemoths led by Rio Tinto congregating atop the risers' list, albeit offset by a motley group of fallers led by consumer goods giant Reckitt Benckiser.London's top tier index closed 0.40% higher to 7,258.75 points. At about 16:50 GMT, shares in Rio Tinto were surging ahead after it confirmed the appointment of three oil- and energy-sector heavyweights to the boards of London-quoted Rio Tinto Plc and Australia-listed Rio Tinto Ltd.The former CEOs of Sasol Ltd and Centrica Plc, respectively David Constable and Sam Laidlaw, would be appointed with immediate effect as independent non-executive directors.Royal Dutch Shell's CFO, Simon Henry, would join the board, also as a non-executive independent director, with effect from 1 July. Two non-exec directors were leaving.Rio Tinto also benefitted alongside the wider blue-chip mining sector -- Antofagasta, Anglo American, Glencore and BHP Billiton all firmly ahead -- aided by well received macro data.The UK trade deficit narrowed to £8.6bn in the fourth quarter, from £14.1bn previously and helped by an increase in exports to countries outside the European Union, the ONS said.Separately, ONS also said UK industrial production rose 1.1% in December, helped by a hike in manufacturing. Economists expected a 0.2% rise. Manufacturing output climbed 2.1% in December, ahead of forecasts for a rise of 0.5%.Construction output edged up 1.8% month-on-month in December, compared to estimates for a 1% rise, and grew 0.6% year-on-year, compared to estimates for a 0.5% fall.Of blue chips retreating, Nurofen and Durex maker Reckitt Benckiser topped the bill on saying it would buy US baby milk company Mead Johnson for up to $17.9bn, including net debt.Reckitt also said its revenue and earnings grew in 2016 despite challenging markets and products.Other sectors notably lower included pharmaceuticals behind Smith & Nephew and Hikma Pharmaceuticals.Shares in BT Group fell as reports confirmed the resignation of its continental Europe chief, Corrado Sciolla, amid the fallout of an accounting scandal at its Italian business. FTSE 100 - RisersRio Tinto (RIO) 3,572.50p 5.63%Antofagasta (ANTO) 866.00p 4.65%Anglo American (AAL) 1,352.50p 4.40%Glencore (GLEN) 320.75p 2.74%BHP Billiton (BLT) 1,370.00p 2.39%Capita (CPI) 525.00p 2.34%Rolls-Royce Holdings (RR.) 732.50p 2.02%BAE Systems (BA.) 612.00p 2.00%Old Mutual (OML) 211.20p 1.78%Fresnillo (FRES) 1,556.00p 1.77%FTSE 100 - FallersReckitt Benckiser Group (RB.) 7,025.00p -2.96%Royal Bank of Scotland Group (RBS) 228.90p -1.80%Convatec Group (CTEC) 240.30p -1.52%Smith & Nephew (SN.) 1,186.00p -1.00%Hikma Pharmaceuticals (HIK) 1,937.00p -0.92%3i Group (III) 714.50p -0.83%Sainsbury (J) (SBRY) 264.60p -0.79%Lloyds Banking Group (LLOY) 65.64p -0.76%Worldpay Group (WPG) 272.00p -0.73%Vodafone Group (VOD) 197.70p -0.70%
More News
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.